Alpha Cubed Investments LLC Purchases 4,620 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Alpha Cubed Investments raised its UnitedHealth stake by 3.7% (adding 4,620 shares), now holding 129,302 shares valued at about $42.68 million — roughly 1.5% of the fund's portfolio and its 18th-largest position.
• Financials and outlook: UnitedHealth beat Q1 EPS estimates ($7.23 vs. $6.76) and set FY‑2026 guidance at an 18.25 EPS midpoint, supporting a "Moderate Buy" analyst consensus and an average price target of $378.88.
• Corporate developments include removing prior‑authorization for about 30% of services (a customer‑centric move) while a shareholder proposal for an independent board chair raises governance questions ahead of the proxy season.

Alpha Cubed Investments LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 129,302 shares of the healthcare conglomerate's stock after acquiring an additional 4,620 shares during the quarter. UnitedHealth Group makes up about 1.5% of Alpha Cubed Investments LLC's investment portfolio, making the stock its 18th largest position. Alpha Cubed Investments LLC's holdings in UnitedHealth Group were worth $42,684,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Beacon Financial Strategies CORP bought a new stake in UnitedHealth Group in the fourth quarter valued at about $26,000. Joseph Group Capital Management acquired a new position in UnitedHealth Group in the fourth quarter valued at about $27,000. Foster Dykema Cabot & Partners LLC grew its stake in UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 34 shares during the period. 1248 Management LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth about $29,000. Finally, Holos Integrated Wealth LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $29,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $363.83 on Wednesday. The firm has a market cap of $330.43 billion, a P/E ratio of 27.48, a price-to-earnings-growth ratio of 1.60 and a beta of 0.64. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $404.72. The business's 50 day moving average is $300.93 and its 200-day moving average is $316.81.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. During the same quarter last year, the company earned $7.20 EPS. The company's revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio (DPR) is presently 66.77%.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the transaction, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.28% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Jefferies Financial Group increased their price objective on UnitedHealth Group from $340.00 to $373.00 and gave the stock a "buy" rating in a report on Monday, April 20th. KeyCorp reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. HSBC raised UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $300.00 price target for the company in a research report on Tuesday, April 7th. UBS Group reduced their price target on UnitedHealth Group from $430.00 to $410.00 and set a "buy" rating for the company in a research report on Wednesday, January 28th. Finally, Royal Bank Of Canada increased their price target on UnitedHealth Group from $361.00 to $400.00 and gave the company an "outperform" rating in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $378.88.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and guidance lift investor sentiment: UnitedHealth reported better-than-expected Q1 results and raised FY‑2026 guidance (18.25 EPS midpoint), which investors see as evidence of improved profitability and underwriting recovery. Why UnitedHealth Group Stock Came Roaring Back In April
• Positive Sentiment: Analyst endorsement: Goldman Sachs added UNH to its U.S. Conviction List and reiterated a $435 price target, signaling confidence that UnitedHealth is near the bottom of its Medicare/underwriting cycle — a supportive catalyst for long‑term holders. Goldman Sachs Names UnitedHealth (UNH) to Conviction List
• Positive Sentiment: Operational move that may improve member experience: UnitedHealthcare will eliminate prior‑authorization requirements for ~30% of services later this year, reducing friction for patients and providers — a customer‑centric step that could support retention and sales narratives. UnitedHealthcare removes prior approval requirements
• Neutral Sentiment: Industry‑wide caution on claims lag: Analysts note that Q1 results may understate recent medical‑cost trends because of claims processing lags; Q2 will be the more important quarter to confirm margin momentum. This tempers immediate upside. Major health insurers show signs of recovery – but a key test looms
• Neutral Sentiment: Talent movement noted: A senior UnitedHealth executive, Heather Cianfrocco, has moved to Highmark Health — routine for large insurers but worth monitoring for any operational impact in benefits/services leadership. Highmark Health Appoints Heather Cianfrocco as Chief Operating Officer
• Negative Sentiment: Governance pressure: A shareholder proposal pushing for an independent board chair (filed by The Accountability Board) has raised governance questions and could be a distraction or source of investor debate ahead of the proxy season. How Investors Are Reacting To UnitedHealth Group (UNH) Earnings Beat, Guidance Hike and Governance Challenge

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.